Procaine Hydrochloride

CHEMBL1200841 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
272.8 g/mol
LogP
Phase
4

A hydrochloride salt form of procaine with the same therapeutic properties. A local anesthetic used to numb a specific area of the body during minor surgical procedures, dental work, or to relieve localized pain by temporarily blocking nerve signals.

Peso Molecular

272,7700 g/mol

TPSA

55,60 Ų

Áreas Terapêuticas

Mecanismo de Ação

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCN(CC)CCOC(=O)c1ccc(N)cc1.Cl

InChI

InChI=1S/C13H20N2O2.ClH/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11;/h5-8H,3-4,9-10,14H2,1-2H3;1H

Molecular Formula

C13H21ClN2O2

HBD / HBA

2 / 4

Ligações Rotacionáveis

7

Átomos Pesados

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A hydrochloride salt form of procaine with the same therapeutic properties. A local anesthetic used to numb a specific area of the body during minor surgical procedures, dental work, or to relieve localized pain by temporarily blocking nerve signals.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Procaine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200841. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5795. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.